92 related articles for article (PubMed ID: 22137316)
1. Clinical profile and outcome of patients of acute myeloid leukemia with high hyperdiploidy.
Sharma SK; Sharma M; Seth T; Mishra P; Chowdhry M; Mahapatra M; Saxena R
Leuk Res; 2012 Mar; 36(3):e60-1. PubMed ID: 22137316
[No Abstract] [Full Text] [Related]
2. Re-analysis of the outcomes of post-remission therapy for acute myeloid leukemia with core binding factor according to years of patient enrollment.
Shin HJ; Kim HJ; Sohn SK; Min YH; Won JH; Kim I; Yoon HJ; Lee JH; Jo DY; Joo YD; Jung CW; Lee KH; ; Chung JS; Ahn JS; Kim SJ; Lee JH; Choi SJ; Lee JH; Bae SH; Hong DS; Zang DY; Kim SH; Lee JL; Bang SM
Jpn J Clin Oncol; 2010 Jun; 40(6):556-66. PubMed ID: 20185460
[TBL] [Abstract][Full Text] [Related]
3. Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial.
Chevallier P; Fornecker L; Lioure B; Béné MC; Pigneux A; Recher C; Witz B; Fegueux N; Bulabois CE; Daliphard S; Bouscary D; Vey N; Delain M; Bay JO; Turlure P; Bernard M; Himberlin C; Luquet I; Ifrah N; Harousseau JL;
Leukemia; 2010 Jul; 24(7):1380-5. PubMed ID: 20508614
[No Abstract] [Full Text] [Related]
4. Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8.
Koh Y; Kim I; Bae JY; Song EY; Kim HK; Yoon SS; Lee DS; Park SS; Park MH; Park S; Kim BK
Jpn J Clin Oncol; 2010 Nov; 40(11):1037-45. PubMed ID: 20587614
[TBL] [Abstract][Full Text] [Related]
5. Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic results.
Ferrara F; Izzo T; Criscuolo C; Riccardi C; Celentano M; Mele G
Am J Hematol; 2010 Sep; 85(9):687-90. PubMed ID: 20652967
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A.
Schlenk RF; Döhner K; Mack S; Stoppel M; Király F; Götze K; Hartmann F; Horst HA; Koller E; Petzer A; Grimminger W; Kobbe G; Glasmacher A; Salwender H; Kirchen H; Haase D; Kremers S; Matzdorff A; Benner A; Döhner H
J Clin Oncol; 2010 Oct; 28(30):4642-8. PubMed ID: 20805454
[TBL] [Abstract][Full Text] [Related]
7. [Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group].
Hübner G; Link H; Schönrock-Nabulsi P; Wandt H; Gramatzki M; Löffler B; Fackler-Schwalbe I; Queisser W; Brack N; Geer T; Raab M; Ohl S; Schneider B; Schneider C; Freund M; Poliwoda H; Ehninger G
Med Klin (Munich); 1996 Apr; 91 Suppl 3():26-32. PubMed ID: 8692115
[TBL] [Abstract][Full Text] [Related]
8. [Acute myeloid leukemia trials by Japan Adult Leukemia Study Group (JALSG)].
Miyazaki Y
Rinsho Ketsueki; 2009 Aug; 50(8):611-6. PubMed ID: 19915375
[No Abstract] [Full Text] [Related]
9. [Russian experts' clinical guidelines for acute myeloid leukemia treatment in patients less than 60 years of age].
Savchenko VG; Parovichnikova EN; Afanas'ev BV; Gritsaev SV; Semochkin SV; Bondarenko SN; Troitskaia VV; Sokolov AN; Kuz'mina LA; Kliasova GA; Baranova OIu; Lapin VA; Konstantinova TS; Samoĭlova OS; Kaporskaia TS; Shatokhin SV
Ter Arkh; 2014; 86(7):4-13. PubMed ID: 25314772
[TBL] [Abstract][Full Text] [Related]
10. Management of acute myeloid leukaemia.
Chopra R
Br J Hosp Med; 1992 Oct 7-20; 48(7):363-75. PubMed ID: 1393232
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of adult patients with acute myeloid leukemia (excluding acute promyelocytic leukemia)].
Usui N
Rinsho Ketsueki; 2014 Oct; 55(10):1808-16. PubMed ID: 25297744
[No Abstract] [Full Text] [Related]
12. [Dose-reduced conditioning before allogeneic stem cell transplantation: principles, clinical protocols and preliminary results].
Schmid C; Weisser M; Ledderose G; Stötzer O; Schleuning M; Kolb HJ
Dtsch Med Wochenschr; 2002 Oct; 127(42):2186-92. PubMed ID: 12397547
[TBL] [Abstract][Full Text] [Related]
13. [Bone marrow transplantation in the treatment of acute leukemias].
Moiseev SI; Ganapiev AA; Abdulkadyrov KM
Ter Arkh; 1996; 68(12):8-10. PubMed ID: 9054052
[TBL] [Abstract][Full Text] [Related]
14. Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy.
Brunet S; Esteve J; Berlanga J; Ribera JM; Bueno J; Martí JM; Bargay J; Guardia R; Juliá A; Granena A; Montserrat E; Sierra J;
Haematologica; 2004 Aug; 89(8):940-9. PubMed ID: 15339677
[TBL] [Abstract][Full Text] [Related]
15. Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission.
Tallman MS; Pérez WS; Lazarus HM; Gale RP; Maziarz RT; Rowe JM; Marks DI; Cahn JY; Bashey A; Bishop MR; Christiansen N; Frankel SR; García JJ; Ilhan O; Laughlin MJ; Liesveld J; Linker C; Litzow MR; Luger S; McCarthy PL; Milone GA; Pavlovsky S; Phillips GL; Russell JA; Saez RA; Schiller G; Sierra J; Weiner RS; Zander AR; Zhang MJ; Keating A; Weisdorf DJ; Horowitz MM
Biol Blood Marrow Transplant; 2006 Feb; 12(2):204-16. PubMed ID: 16443518
[TBL] [Abstract][Full Text] [Related]
16. Treatment for adult acute myeloid leukemia: where we stand in 1995.
Wiernik PH
Acta Haematol Pol; 1995; 26(3):231-7. PubMed ID: 8525767
[No Abstract] [Full Text] [Related]
17. Acute myelogenous leukemia in Chile PINDA protocols 87 and 92 results.
Quintana J; Advis P; Becker A; Beresi V; Campbell M; Vinés EF; García H; Salgado C; Vargas L; Rojas J; Obando M; Neira L; Páez E; Zolezzi P
Leukemia; 2005 Dec; 19(12):2143-6. PubMed ID: 16304574
[No Abstract] [Full Text] [Related]
18. Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome.
Schmid C; Schleuning M; Ledderose G; Tischer J; Kolb HJ
J Clin Oncol; 2005 Aug; 23(24):5675-87. PubMed ID: 16110027
[TBL] [Abstract][Full Text] [Related]
19. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
Zittoun RA; Mandelli F; Willemze R; de Witte T; Labar B; Resegotti L; Leoni F; Damasio E; Visani G; Papa G
N Engl J Med; 1995 Jan; 332(4):217-23. PubMed ID: 7808487
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
